'Global Clinical Infrastructure Expansion' C&R Research... Establishes Corporations in Thailand and the United States

Contract Research Organization (CRO) C&R Research announced on the 22nd that it has established an overseas subsidiary in Thailand to proactively conduct global clinical trials.

C&R Research plans to expand its clinical trial market in Southeast Asia based on Thailand's stable medical infrastructure and high-quality clinical trial personnel. Centered on Chiang Mai Hospital in Thailand, the company aims to provide cost-effective and high-standard clinical trials, and is coordinating with several domestic sponsors to conduct numerous global clinical trials, including vaccine-related research.

The name of C&R Research’s Thai subsidiary has been decided as "C&R Healthcare Global Thailand." The representative will be Director Kim Yun-ho, who is in charge of business development at C&R Research. The company explained, “The establishment of the Thai subsidiary aims to respond to the demand from domestic sponsors in Southeast Asia, independently conduct global clinical trials, and utilize local networks for clinical trial execution.”

C&R Research also established an overseas subsidiary in the United States called "C&R Research US," targeting the North American market. A C&R Research representative stated, “We will gradually expand our scope of operations, starting with tasks related to the U.S. Food and Drug Administration (FDA) Pre-IND and IND approval processes.”